Clinical Trials in Salt Lake City

Showing 10661-10680 of 14,325 trials

The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects

NCT02516436

A randomized, double blind, active controlled study in approximately 40 opioid dependent subjects. Study duration is up to five days and includes a maximum of 3 days confinement in the clinic. Opioid dependent subjects who provide informed consent meet all entry criteria are eligible for enrollment into the study.

Opioid Dependence

BioDelivery Sciences International

Birmingham, Alabama, United States • Orem, Utah, United States • Salt Lake City, Utah, United States

COMPLETEDPhase 3< 1 mile

Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma

NCT01928771

The purpose of this study is to determine whether Benralizumab reduces the number of asthma exacerbations in patients who remain uncontrolled on high doses of ICS-LABA.

Asthma

AstraZeneca2,681 participantsStarted Sep 2013

Foley, Alabama, United States • Huntsville, Alabama, United States • Mobile, Alabama, United States +272 more locations

The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects

Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma

Find Trials by Condition in Salt Lake City

A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease

Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis

Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)

Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes

PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1

Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA

Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)

Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma

Inhibitor Development in Patients With Hemophilia A Undergoing Surgery

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies

A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Educational Program for Various Health Literacy Levels to Improve the Health of Individuals With Heart Failure

Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy

A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)

Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration

Vilazodone for the Treatment of Posttraumatic Stress Disorder